Haloperidol Richter (Haloperidol)

Haloperidol Richter is indicated for the management of several acute and chronic psychiatric disorders where dopamine blockade is therapeutic.

• Schizophrenia, including maintenance therapy.
• Acute psychotic episodes or exacerbations.
• Severe agitation requiring rapid control.
• Tourette syndrome with motor and vocal tics.
• Short‑term treatment of acute mania when clinically appropriate.

Side effects of haloperidol may vary in frequency and severity; they are typically categorized as common or serious.

Common

• Drowsiness or sedation.
• Extrapyramidal symptoms such as tremor, rigidity, or akathisia.
• Dry mouth.
• Constipation.
• Blurred vision.

Serious

• Neuroleptic malignant syndrome.
• Cardiac arrhythmias, including QT prolongation and torsades de pointes.
• Severe hypotension.
• Elevated prolactin levels leading to galactorrhea or menstrual disturbances.

When prescribing Haloperidol Richter, clinicians consider several precautionary measures to minimize risks and ensure appropriate use.

• Assess patient history for cardiovascular disease, especially conditions that predispose to QT prolongation.
• Evaluate for existing movement disorders or Parkinsonian features before initiating therapy.
• Use the lowest effective dose, particularly in elderly patients, to reduce sedation and fall risk.
• Monitor for signs of neuroleptic malignant syndrome throughout treatment.
• Consider pregnancy and lactation status; haloperidol is classified as pregnancy category unknown and should be used only if benefits outweigh potential risks.
• Review hepatic and renal function periodically to adjust dosing if necessary.

Haloperidol can interact with other medications, influencing its efficacy or safety profile.

Avoid

• Concurrent use with other dopamine antagonists or antipsychotics, which may increase extrapyramidal risk.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that raise haloperidol plasma concentrations.
• QT‑prolonging agents such as quinidine, sotalol, or certain antiemetics, increasing the risk of cardiac arrhythmias.

Use with caution

• Central nervous system depressants (e.g., benzodiazepines, opioids) that may enhance sedation.
• Anticholinergic drugs, which can mask extrapyramidal symptoms.
• Lithium, as combined therapy may increase neurotoxicity.